Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...
WMBD Peoria on MSN
Advances in HIV treatment allow for safe intimacy and marriage
Andy Feds, a comedian born with HIV, married his wife Jasmine Collins-Badeau, who is not living with HIV, and they are ...
Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Pharmaceutical Technology on MSN
JPM26: HIV pipeline dosing optionality gives Gilead advantage
Speaking at the J.P. Morgan Healthcare Conference 2026, CEO Daniel O’Day said that the company has seven pipeline drugs for ...
The National Alliance of State and Territorial AIDS Directors estimates more than 16,000 Floridians will lose coverage.
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
At least 1.4 million Kenyans are living with HIV, with approximately 21,009 people estimated to have died from AIDS-related ...
The Assembly Appropriations Committee has advanced legislation allowing New Jersey pharmacists to dispense HIV prevention ...
A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback